Versant Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 1657 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1663 |
|
|
2019
Q2 | $0 | Sell |
1
-5
| -83% | – | ﹤0.01% | 1793 |
|
|
2019
Q1 | $9K | Sell |
6
-5
| -45% | -$7.5K | ﹤0.01% | 955 |
|
|
2018
Q4 | $19K | Buy |
11
+1
| +10% | +$1.73K | 0.01% | 567 |
|
|
2018
Q3 | $24K | Sell |
10
-1
| -9% | -$2.4K | 0.01% | 556 |
|
|
2018
Q2 | $37K | Hold |
11
| – | – | 0.02% | 393 |
|
|
2018
Q1 | $32K | Hold |
11
| – | – | 0.01% | 440 |
|
|
2017
Q4 | $28K | Sell |
11
-3
| -21% | -$7.64K | 0.01% | 514 |
|
|
2017
Q3 | $39K | Buy |
14
+4
| +40% | +$11.1K | 0.02% | 342 |
|
|
2017
Q2 | $24K | Buy |
10
+4
| +67% | +$9.6K | 0.01% | 523 |
|
|
2017
Q1 | $15K | Buy |
+6
| New | +$15K | 0.01% | 701 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 1576 |
|
|
2016
Q3 | – | Hold |
0
| – | -$1K | – | 1333 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$3K | – | 1302 |
|
|
2016
Q1 | $3K | Sell |
1
-1
| -50% | -$3K | ﹤0.01% | 1087 |
|
|
2015
Q4 | $7K | Buy |
+2
| New | +$7K | ﹤0.01% | 866 |
|